Recommended Prescription for Cellulitis Without MRSA Risk
For adults with uncomplicated, non-purulent cellulitis and no MRSA risk factors, prescribe cephalexin 500 mg four times daily orally for 5 days, or alternatively dicloxacillin 500 mg four times daily orally. 1
Rationale and Treatment Algorithm
The IDSA 2014 guidelines clearly establish that non-purulent cellulitis should be treated targeting β-hemolytic Streptococcus and methicillin-sensitive Staphylococcus aureus (MSSA) 1. This recommendation is strongly supported by microbiological evidence showing that streptococci are the predominant causative organisms in most cases 2, 3.
First-Line Oral Antibiotics (in order of preference):
For penicillin-tolerant patients:
- Cephalexin 500 mg four times daily 1
- Dicloxacillin 500 mg four times daily (oral agent of choice for MSSA in adults) 1
For penicillin-allergic patients (non-immediate hypersensitivity):
- Cephalexin remains an option 1
For immediate penicillin hypersensitivity:
Treatment Duration
Five days of treatment is sufficient if symptoms are improving; extend only if no improvement is observed 2.
Why MRSA Coverage Is NOT Needed
Multiple lines of evidence support withholding empirical MRSA coverage in your scenario:
Non-purulent cellulitis is predominantly streptococcal 3, 4. Even in communities with high MRSA prevalence, empirical beta-lactam therapy directed at streptococci is sufficient 3.
Clinical trial data demonstrate comparable cure rates with penicillin monotherapy versus broader-spectrum antibiotics 5, suggesting MSSA may not even be a major contributor to non-purulent cellulitis.
Cost-effectiveness analyses show cephalexin remains the most cost-effective option at current MRSA prevalence levels, with clindamycin only becoming preferable when MRSA probability exceeds 41-80% AND staphylococcal infection probability exceeds 40% 6.
When to Consider MRSA Coverage
Reserve MRSA-active antibiotics (trimethoprim-sulfamethoxazole, clindamycin, doxycycline) for patients with specific risk factors 2:
- Athletes, children in daycare
- Men who have sex with men
- Prisoners, military recruits
- Long-term care facility residents
- Prior MRSA exposure/infection
- Intravenous drug users
- Purulent/suppurative cellulitis with abscess formation
- Presence of SIRS criteria (fever >38°C or <36°C, tachycardia >90, tachypnea >24, WBC >12,000 or <4,000) 1
Common Pitfalls to Avoid
Over-prescribing MRSA coverage: The majority of non-purulent cellulitis cases do not require MRSA coverage despite rising community MRSA rates 4.
Misdiagnosis: Cellulitis mimics (venous stasis dermatitis, contact dermatitis, eczema) are common and do not require antibiotics 4. Look for acute onset of erythema, warmth, swelling, and tenderness.
Constitutional symptoms as diagnostic clues: Early fever and chills (occurring at or before erythema onset) strongly suggest streptococcal erysipelas, which responds reliably to penicillin 7. Cellulitis patients typically develop constitutional symptoms later, if at all.
Unnecessary treatment extension: If no improvement after 5 days on appropriate first-line therapy, consider resistant organisms, cellulitis mimics, or underlying conditions (immunosuppression, chronic liver/kidney disease) rather than automatically extending the same antibiotic 2.